Observations placeholder
Toviaz
Identifier
020221
Type of Spiritual Experience
Background
A description of the experience
Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug to treat overactive bladder syndrome (OAB). Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.
Efficacy
Fesoterodine has the advantage of allowing more flexible dosage than other muscarinic antagonists. Its tolerability and side effects are similar to other muscarinic antagonists and as a new drug seems unlikely to make great changes in practices of treatment for overactive bladder
On Dec, 16, 2016 6,360 people reported to have side effects when taking Toviaz.
Among them, 23 people (0.36%) have Hallucination
Time on Toviaz when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 75.00% | 25.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Feb, 13, 2016: 3,381 people reported to have side effects when taking Toviaz. Among them, 32 people (0.95%) have Death.
Time on Toviaz when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 75.00% | 0.00% | 0.00% | 25.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Toviaz :
Female | Male | |
Death | 48.15% | 51.85% |
Age of people who have Death when taking Toviaz :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 0.00% | 0.00% | 0.00% | 0.00% | 14.29% | 0.00% | 14.29% | 71.43% |
Top conditions involved for these people :
- Urinary incontinence (5 people, 15.62%)
The source of the experience
eHealthmeConcepts, symbols and science items
Concepts
Symbols
Science Items
Activities and commonsteps
Activities
Overloads
AnticholinergicsBladder and urinary tract disease
Urinary and bladder control treatments